UroGen Pharma Ltd.

Historical 13F Holders

Symbol
URGN
CUSIP
M96088105
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for M96088105 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 6.3% 10/27/2026
Event 9/30/2026
Toronto Dominion Bank 13G/A
5.7% 11/13/2026
Event 9/30/2026
Morgan Stanley 13G 5.4% 8/6/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Menora Mivtachim Holdings Ltd 13G/A 4.99% 3/17/2025
Event 3/11/2025
Soleus Capital Master Fund, L.P. 13G/A
4.7% 8/5/2025
Event 6/30/2025
Paradigm Biocapital Advisors LP 13G/A
3.5% 5/15/2026
Event 3/31/2026
Adage Capital Management, L.P. 13G/A
2.8% 5/12/2025
Event 3/31/2025
Monograph Capital Holdings Advisors, LLC 13D/A
1.9% 6/9/2025
Event 6/5/2025
Cowen Financial Products LLC 13G/A 0% 11/14/2025
Event 9/30/2025
RA Capital Management, L.P. 13G/A
0% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 223 40.6 M $1.73B
2026 Q2 191 42.4 M $1.56B
2026 Q1 175 46.4 M $835M
2025 Q4 170 43.7 M $1.02B
2025 Q3 163 44.0 M $877M
2025 Q2 154 39.8 M $545M
2025 Q1 141 41.6 M $461M
2024 Q4 139 36.3 M $386M
2024 Q3 129 35.1 M $446M
2024 Q2 117 38.2 M $641M
2024 Q1 113 27.2 M $407M
2023 Q4 107 21.4 M $321M
2023 Q3 103 17.7 M $248M
2023 Q2 87 13.3 M $138M
2023 Q1 68 12.5 M $116M
2022 Q4 66 13.0 M $115M
2022 Q3 62 13.3 M $111M
2022 Q2 66 13.4 M $109M
2022 Q1 85 14.2 M $124M
2021 Q4 79 14.7 M $140M
2021 Q3 94 14.1 M $237M
2021 Q2 83 14.0 M $214M
2021 Q1 90 14.3 M $279M
2020 Q4 83 14.5 M $262M
2020 Q3 81 15.0 M $289M
2020 Q2 85 14.7 M $382M
2020 Q1 80 14.0 M $249M
2019 Q4 87 14.2 M $473M
2019 Q3 85 14.6 M $347M
2019 Q2 85 14.7 M $527M
2019 Q1 77 13.5 M $498M
2018 Q4 65 9.59 M $413M
2018 Q3 72 9.95 M $470M
2018 Q2 60 9.61 M $483M
2018 Q1 43 9.14 M $454M
2017 Q4 41 6.84 M $254M
2017 Q3 32 4.61 M $145M
2017 Q2 21 4.72 M $85.2M